Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanjay Shukla Insider Profile
18 Followers
Sanjay Shukla, President & CEO, Director at aTyr Pharma, holds 136.55K shares in aTyr Pharma (Ticker: ATYR). Most recently, Sanjay Shukla Bought $20,000 shares of aTyr Pharma on Jun 03, 2024 for an estimated value of 36.00K.
Sanjay Shukla aTyr Pharma (ATYR)President & CEO, Director
aTyr Pharma (ATYR)
President & CEO, Director
Ranked #10,654 out of 99,335 Corporate Insiders
Profitable Transactions
4 out of 10 Profitable Transactions
Average Return
+17.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Sanjay Shukla holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sanjay Shukla
Sanjay Shukla's Trading History
List of latest transactions for each holding click on a transaction to see Sanjay Shukla's performance on stock
You May Also Like
Sanjay Shukla insider profile FAQ
What is the percentage of profitable transactions made by Sanjay Shukla?
The percentage of profitable transactions made by Sanjay Shukla is 40%.
What is the average return per transaction made by Sanjay Shukla?
The average return per transaction made by Sanjay Shukla is 17.70%.
What stocks does Sanjay Shukla hold?
Sanjay Shukla holds: ATYR stocks.
What was Sanjay Shukla’s latest transaction?
Sanjay Shukla latest transaction was an Informative Buy of $36.00K.
What was Sanjay Shukla's most profitable transaction?
Sanjay Shukla’s most profitable transaction was an Informative Buy of ATYR stock on November 13, 2023. The return on the trade was 179.80%.
What is Sanjay Shukla's role in aTyr Pharma?
Sanjay Shukla's role in aTyr Pharma is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.